Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes.

Biotechnology

Acticor Biotech

Gilles Avenard

Patricia Zilliox

Antoine Lebel

Sandra Lourenço-Lopes

Alexandra Brochand

Véronia Safwat

Sophie Binay

Marion Galaup

Eric Cohen

Elie Toledano

Victoria Rutman

Yannick Plétan

Laurie Jullien

Clinical Operations Team

Medical Team

Regulatory and Quality Team

Scientific & Pharmaceutical Development

Leadership Team

Teams at Acticor Biotech

Clinical Operations Team

Medical Team

Regulatory and Quality Team

Scientific & Pharmaceutical Development

Leadership Team